Table 1.
Groups | Before treatment | After treatment | ||||
---|---|---|---|---|---|---|
Serum Testosteronenmol L−1 | Serum DHTnmol L−1 | Serum Testosteronenmol L−1 | Serum DHTnmol L−1 | Intra‐prostatic Testosteronenmol g−1 tissue | Intra‐prostatic DHTnmol g−1 tissue | |
Control group | 16.32 ± 2.50 | 4.02 ± 0.486 | 17.06 ± 3.87 | 3.98 ± 0.50 | 70.26 ± 6.87 | 45.42 ± 3.48 |
Testosterone group | 18.52 ± 3.62 | 3.91 ± 0.463 | 25.16 ± 3.80 | 4.99 ± 0.67 | 96.79 ± 7.72 | 64.58 ± 4.00 |
Finasteride group | 16.75 ± 3.02 | 4.13 ± 0.517 | 19.87 ± 4.13 | 2.35 ± 0.41 | 83.09 ± 10.95 | 23.61 ± 1.68 |